![]() Back to Annual Meeting
|
|
![]() Back to Annual Meeting
|
APHA Scientific Session and Event Listing |
Nadine Levick, MD, MPH, Division of Research, EMS Safety Foundation, 137 Central Park North, New York, NY 10026, 917.4932001, nlevick@attglobal.net and John Russell, MD, Cape County Private Ambulance Service, 1458 North Kingshighway, Cape Girardeau, MO 63701.
Use of lights and sirens (L/S) has been shown to increase hazards for EMS transport.
Objective: To determine response outcome of changing ‘to scene' Emergency ‘L/S' responses to Immediate ‘no L/S' modality for a defined cohort of runs.
Methodology: Pilot study conducted in a 911 provider regional EMS system serving 100,000 people, using Medical Priority Dispatch System, a validated dispatch system, classifying runs by increasing severity: Alpha, Bravo, Charlie, Delta, Echo. Alpha trips were run ‘no L/S' since 1992. The intervention, to change Bravo responses from ‘L/S' to ‘no L/S' responses, commenced in March 2005. Data was collected the last 6 months of 2004 and the last 6 months of 2005. A comparison of response category, run data and ‘L/S' use was performed.
Results: During the study periods call distribution, weather, and demand factors were similar. In the 2004 period 2495 runs, and 2005 period 2780 runs, Bravo responses were 28% and 25% respectively. Changing Bravo ‘to scene' responses to Immediate ‘no L/S' resulted in the expected 25% decrease in ‘L/S' responses and there was no increase in total ‘from scene' ‘L/S' transports. There was an 8% decrease in Emergency ‘L/S' responses where there was no patient found or no transport.
Conclusion: A policy replacing potentially hazardous use of ‘to scene' Emergency L/S responses in this cohort with Immediate ‘no L/S' responses resulted in a substantial decrease in potential transport hazards. Generalizability would require a larger sample size. Defining response modalities is where prioritization of dispatch can pay safety dividends.
Learning Objectives:
Keywords: EMS/Trauma, Quality Improvement
Related Web page: www.objectivesafety.net
Presenting author's disclosure statement:
Any relevant financial relationships? No
Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
The 135th APHA Annual Meeting & Exposition (November 3-7, 2007) of APHA